Getting to Commercial Manufacturing: Producing Therapies for Patient Need

18 Jan 2023
Manufacturing Advanced Therapies Track
Adva Biotechnology

11:00am Chair Introduction

Ohad Karnieli, Chief Executive Officer, Adva Biotechnology 


11:05am Presentation: TBA

Don Healey, Chief Technology Officer, Adicet Bio


11:20am Presentation: Cell Culture Media: Myths, Realities, and the Importance of Ownership

David Sheehan, President & Chief Executive Officer, Nucleus Biologics


11:35am Presentation: TBA

Lesley Chan, Director of Cellular Process Development, bluebird bio


11:50am Presentation: Gene and Cell Therapy: A Patient Perspective

J Kelly Ganjei, President and Chief Executive Officer, Amplify Bio


12:05pm Closing Panel with Q&A

With all session participants


David Sheehan
President & Chief Executive Officer
Nucleus Biologics
Don Healey
Chief Technology Officer
Adicet Bio
J Kelly Ganjei
President and Chief Executive Officer
Lesley Chan
Director of Process Innovation
bluebird bio
Ohad Karneili
Chief Executive Officer
Adva Biotechnology